Webinar
Defining the ROI of Patient Engagement in MedTech Product Development
SHARE
Milken Institute's FasterCures team recently hosted a virtual public convening on the topic of in the value and return on investment of patient engagement in medical technology product development.
SHARE
Related Content
-
Defining and Demonstrating the Value of Patient Engagement in Medtech Research and Product Development
In 2022, FasterCures published a report titled The Current Landscape of the Science of Patient Input, which examined the progress of patient engagement (PE) in biomedical research and identified ways to overcome ongoing challenges. Building...Read Report
-
Patient Engagement in Care Delivery: Approaches by Health-Care Providers
Patient engagement is a critical component at every stage of the health care ecosystem, from drug development to care delivery.Read Report
-
Prescription for Biomedical Innovation: Recommendations for the New Administration
FasterCures has long been at the forefront of shaping the national focus on biomedical innovation, with a singular goal of saving lives by accelerating scientific advances for all patients. FasterCures has been instrumental in advocating...Read Report -
The Current Landscape of the Science of Patient Input
In the last decade, FasterCures and many stakeholders across the biomedical research ecosystem have driven initiatives to ensure that patients’ perspectives and input are appropriately represented across the product-development continuum...Read Report
HO
-
Lessons Learned From COVID-19: Are There Silver Linings for Biomedical Innovation?
FasterCures wants to ensure that the lessons of the COVID-19 crisis are not lost once the current urgency subsides — not only for combating future infectious diseases, but for conducting every other aspect of biomedical innovation...Read Report
-
Medicare Drug Price Negotiation Program Draft Guidance
The FasterCures team at the Milken Institute is honored to provide its expert response to the Request for Comments on the Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191–1198 of the Social Security...Read LetterImage
Esther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives. -
Milken Institute Statement on US Federal Investment in Biomedical Research
For nearly a century, active US federal investment in biomedical research has delivered breakthroughs that cure diseases, improve quality of life, and drive economic growth. Each dollar the National Institutes of Health (NIH) invests...Read Article